
|Videos|September 15, 2021
Dr. Kaufman hails autologous muscle-derived cells as "transformational" SUI treatment
Author(s)Urology Times staff
“This technology is truly a transformational opportunity for urology,” says Melissa R. Kaufman, MD, PhD, FACS.
Advertisement
In this video, Melissa R. Kaufman, MD, PhD, FACS, discusses autologous muscle derived cells for urinary sphincter repair (AMDC-USR) and how this technology is designed to treat stress urinary incontinence (SUI) in female patients. Kaufman is a professor of urology and chief of the division of reconstructive urology and pelvic health at Vanderbilt University, Nashville, Tennessee.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Testosterone deficiency: FAQs from the AUA guideline
3
Joshua Lang, MD, MS, on integrating molecular biomarkers into clinical practice
4
Large registry study reports durable 10-year outcomes with focal therapy for prostate cancer
5












